What is Novonesis (Novozymes) B Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novonesis (Novozymes) B's Average Total Inventories for the quarter that ended in Mar. 2025 was $772 Mil. Novonesis (Novozymes) B's Revenue for the
three
months ended in Mar. 2025 was $1,165 Mil.
Novonesis (Novozymes) B's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.66.
Novonesis (Novozymes) B's Inventory-to-Revenue for the quarter that ended in Mar. 2025
increased
from Dec. 2024 (0.36) to Dec. 2024 (0.66)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Novonesis (Novozymes) B's Days Inventory for the
three
months ended in Mar. 2025 was 134.83.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Novonesis (Novozymes) B's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.68.
Novonesis (Novozymes) B Inventory-to-Revenue Historical Data
The historical data trend for Novonesis (Novozymes) B's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Novonesis (Novozymes) B Inventory-to-Revenue Chart
Competitive Comparison of Novonesis (Novozymes) B's Inventory-to-Revenue
For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novonesis (Novozymes) B's Inventory-to-Revenue Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Novonesis (Novozymes) B's Inventory-to-Revenue falls into.
Novonesis (Novozymes) B Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novonesis (Novozymes) B's Inventory-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novonesis (Novozymes) B (OTCPK:NVZMF) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Novonesis (Novozymes) B's Days Inventory for the
three
months ended in Mar. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novonesis (Novozymes) B Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NVZMF has been successfully added to your 